Drug Formulation Market Report 2026

Drug Formulation Market Overview

• Drug Formulation market size has reached to $2045.31 billion in 2025 • Expected to grow to $3196.24 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Rising Adoption Of Personalized Medicine To Drive Market Growth • Market Trend: Product Innovations Transforming The Drug Formulation Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Formulation Market?

Drug formulation is defined as the process of combining several chemical and biological ingredients, including the active medicine, to create a finished pharmaceutical product. It is used to be modify and optimize the drugs during the preclinical stage and initial research. The main types of dosage forms for drug formulations are oral formulations, parenteral formulations, topical formulations, and inhalation formulations. Oral formulation is defined as the development and manufacturing of pharmaceuticals designed for oral delivery. They have different formulations forms, such as tablets, capsules, injectables, sprays, suspensions, powders, and others, that are used in cardiovascular diseases (CVDs), pain, diabetes, cancer, respiratory diseases, and others. These are used by several end-users, including big pharma companies, small and medium enterprises, and biotech companies.

What Is The Drug Formulation Market Growth Forecast?

The drug formulation market size is expected to see strong growth in the next few years. It will grow to $3196.24 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to emergence of gene and cell therapies, adoption of AI in drug design, development of novel excipients, increase in biologics and specialty drugs, expansion of emerging pharmaceutical markets. Major trends in the forecast period include personalized drug formulations, advanced drug delivery systems, biologics and biosimilars development, formulation stability and shelf-life optimization, regulatory compliance and quality assurance.

Global Drug Formulation Market Segmentation

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations 2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations 3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases 4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies Subsegments: 1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions 2) By Parenteral Formulations: Injectables, Implants, Infusions 3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches 4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

What Is The Driver Of The Drug Formulation Market?

The increasing adoption of personalized medicine is expected to propel the growth of the drug formulation market going forward. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the individual characteristics of each patient. Personalized medicine involves tailoring treatments based on individual patient characteristics, such as genetics and biomarkers. This approach necessitates the development of customized drug formulations to optimize efficacy and safety for each patient. The impact includes the need for individualized treatment plans, formulations accommodating genomic insights, optimized drug responses, and tailored therapies for rare diseases. For instance, in 2023, according to the Personalized Medicine Coalition (PMC), a US-based non-profit, personalized medicines accounted for approximately 38 percent of all newly approved therapeutic molecular entities, up from 34 percent in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the drug formulation industry.

Key Players In The Global Drug Formulation Market

Major companies operating in the drug formulation market are AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Global Drug Formulation Market Trends and Insights

Major companies operating in the drug formulation market are developing new fixed dose combination drugs for type 2 diabetes to gain a competitive edge in the market. Fixed Dose Combination (FDC) refers to a pharmaceutical formulation that contains two or more active ingredients combined in a fixed ratio of doses within a single dosage form. For instance, in October 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company launched first triple-drug fixed-dose combination under the brand name Zita DM. It contains the DPP4 inhibitor, Teneligliptin (20mg), the SGLT2 inhibitor, Dapagliflozin, (10mg), and Metformin SR (500mg/1000mg) in a fixed dose. It must be taken once daily, under prescription, to improve glycemic control in patients with Type 2 diabetes.

What Are Latest Mergers And Acquisitions In The Drug Formulation Market?

In May 2025, Roquette, a France-based provider of plant-based ingredients and pharmaceutical excipients, acquired IFF Pharma Solutions for an undisclosed amount. With this acquisition, Roquette aims to strengthen its position in the global pharmaceutical excipients market and enhance its drug-delivery capabilities by integrating IFF’s innovation portfolio and technical expertise. IFF Pharma Solutions is a US-based business that develops and manufactures pharmaceutical excipients and specialty solutions for oral dosage forms.

Regional Insights

North America was the largest region in the drug formulation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug Formulation Market?

The drug formulation market includes revenues earned by entities by providing formulation optimization, process optimization, and scale-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug Formulation Market Report 2026?

The drug formulation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug formulation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.